The detection limits for estimates of infection intensity in schistosomiasis mansoni established by a study in non-human primates

International Journal for Parasitology

Volumn 36, Issue 12, 2006, Pages 1241-1244

  Alan Wilson, R ^a   van Dam, Govert J ^b   Kariuki, Thomas M ^c   Farah, Idle O ^c   Deelder, André M ^b   Coulson, Patricia S ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c INSTITUTE OF PRIMATE RESEARCH   (Kenya)

Author keywords

Baboon; Chemotherapy; Circulating antigens; Faecal eggs; Schistosoma; Vaccine

Indexed keywords

ANTIGEN; VACCINE;

DETECTION METHOD; DISEASE PREVALENCE; PARASITE INTENSITY; PRIMATE; REGRESSION ANALYSIS; SCHISTOSOMIASIS;

ARTICLE; DISEASE CONTROL; DISEASE SEVERITY; FECES ANALYSIS; HOST PARASITE INTERACTION; NONHUMAN; PARASITE IDENTIFICATION; PREVALENCE; PRIMATE; QUANTITATIVE ANALYSIS; REGRESSION ANALYSIS; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS;

ANIMALS; ANTIGENS, HELMINTH; FECES; PAPIO ANUBIS; PARASITE EGG COUNT; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; VACCINES, ATTENUATED;

PAPIO HAMADRYAS; PRIMATES; SCHISTOSOMA;

EID: 33748632659     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2006.07.002     Document Type: Article

References (22)

1. Agnew A., Fulford A.J., De Jonge N., Krijger F.W., Rodriguez-Chacon M., Gutsmann V., and Deelder A.M. The relationship between worm burden and levels of a circulating antigen (CAA) of five species of Schistosoma in mice. Parasitology 111 (1995) 67-76
2. Barsoum I.S., Colley D.G., and Kamal K.A. Schistosoma mansoni: detection of circulating antigens in murine schistosomiasis by antigen-capture sandwich ELISA using a monoclonal antibody. Exp. Parasitol. 71 (1990) 107-113
3. Berhe N., Medhin G., Erko B., Smith T., Gedamu S., Bereded D., Moore R., Habte E., Redda A., Gebre-Michael T., and Gundersen S.G. Variations in helminth faecal egg counts in Kato-Katz thick smears and their implications in assessing infection status with Schistosoma mansoni. Acta Trop. 92 (2004) 205-212
4. Chitsulo L., Engels D., Montresor A., and Savioli L. The global status of schistosomiasis and its control. Acta Trop. 77 (2000) 41-51
5. de Vlas S.J., and Gryseels B. Underestimation of Schistosoma mansoni prevalences. Parasitol. Today 8 (1992) 274-277
6. de Vlas S.J., Gryseels B., van Oortmarssen G.J., Polderman A.M., and Habbema J.D. A pocket chart to estimate true Schistosoma mansoni prevalences. Parasitol. Today 9 (1993) 305-307
7. De Vlas S.J., Engels D., Rabello A.L., Oostburg B.F., Van Lieshout L., Polderman A.M., Van Oortmarssen G.J., Habbema J.D., and Gryseels B. Validation of a chart to estimate true Schistosoma mansoni prevalences from simple egg counts. Parasitology 114 (1997) 113-121
8. Deelder A.M., De Jonge N., Boerman O.C., Fillie Y.E., Hilberath G.W., Rotmans J.P., Gerritse M.J., and Schut D.W. Sensitive determination of circulating anodic antigen in Schistosoma mansoni infected individuals by an enzyme-linked immunosorbent assay using monoclonal antibodies. Am. J. Trop. Med. Hyg. 40 (1989) 268-272
9. Fenwick A. New initiatives against Africa's worms. Trans. R. Soc. Trop. Med. Hyg. 100 (2006) 200-207
10. Kariuki T.M., Farah I.O., Yole D.S., Mwenda J.M., Van Dam G.J., Deelder A.M., Wilson R.A., and Coulson P.S. Parameters of the attenuated schistosome vaccine evaluated in the olive baboon. Infect. Immun. 72 (2004) 5526-5529
11. Kariuki T.M., Van Dam G.J., Deelder A.M., Farah I.O., Yole D.S., Wilson R.A., and Coulson P.S. Previous or ongoing schistosome infections do not compromise the efficacy of the attenuated cercaria vaccine. Infect. Immun. 74 (2006) 3979-3986
12. Katz N., Chaves A., and Pellegrino J. A simple device for quantitative stool thick-smear technique in schistosomiasis mansoni. Rev. Inst. Med. Trop. Sao Paulo 14 (1972) 397-400
13. King C.H., Dickman K., and Tisch D.J. Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 365 (2005) 1561-1569
14. In: Murray C.J.L., and Lopez A.D. (Eds). The Global Burden of Disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020 (1996), Harvard School of Medical Health, Cambridge, MA
15. Polman K., Engels D., Fathers L., Deelder A.M., and Gryseels B. Day-to-day fluctuation of schistosome circulating antigen levels in serum and urine of humans infected with Schistosoma mansoni in Burundi. Am. J. Trop. Med. Hyg. 59 (1998) 150-154
16. Polman K., Diakhate M.M., Engels D., Nahimana S., Van Dam G.J., Falcao Ferreira S.T., Deelder A.M., and Gryseels B. Specificity of circulating antigen detection for schistosomiasis mansoni in Senegal and Burundi. Trop. Med. Int. Health 5 (2000) 534-537
17. Steinmann P., Keiser J., Bos R., Tanner M., and Utzinger J. Schistosomiasis and water resources development: systematic review, meta-analysis and estimates of people at risk. Lancet Infect. Dis. 6 (2006) 411-425
18. Utzinger J., N'Goran E.K., N'Dri A., Lengeler C., and Tanner M. Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection. Trop. Med. Int. Health 5 (2000) 771-778
19. Utzinger J., Zhou X.N., Chen M.G., and Bergquist R. Conquering schistosomiasis in China: the long march. Acta Trop. 96 (2005) 69-96
20. van der Werf M.J., de Vlas S.J., Brooker S., Looman C.W., Nagelkerke N.J., Habbema J.D., and Engels D. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop. 86 (2003) 125-139
21. van Lieshout L., Polderman A.M., and Deelder A.M. Immunodiagnosis of schistosomiasis by determination of the circulating antigens CAA and CCA, in particular in individuals with recent or light infections. Acta Trop. 77 (2000) 69-80
22. WHO, 2004. The World Health Report. Changing history. Statistical Annex. p. 120. Available from: .